Their experiments show that LCN2 is associated with dermal fibrosis in early Diffuse Cutaneous SSc cases (some of which are also diagnosed with ILD) but not with ILD markers such as diffusion lung capacity for carbon monoxide or vital capacity [40]. This evidence concerns the gene LCN2 and interstitial lung disease.